Drug Therapies for COVID-19

Research studies involving thousands of people have allowed scientists to test which drugs are effective at treating COVID-19. Several drug therapies are now available to treat people who are in hospital with COVID-19, or to prevent infections in vulnerable people becoming more serious. This briefing explains which drugs are available, the groups of people in which they are used and how they work. It also outlines the importance of monitoring the emergence of new variants and drug resistance.

Drug Therapies for COVID-19

COVID-19: Omicron, recent developments, and the likely impact of future variants on the pandemic

The Omicron variant of the SARS-CoV-2 virus, which causes COVID-19, has been found across the world since it was first detected in early November 2021. This article describes the characteristics of the variant and its health impacts. It also discusses vaccine effectiveness against the variant and the medium and long-term outlook for the future course of the pandemic.

COVID-19: Omicron, recent developments, and the likely impact of future variants on the pandemic

Total results (page 1 of 8)